RECAM Suspected Offending Drug Drug1 Drug2 Drug3 Drug4 Date Starting Suspected Drug Date of Stopping Suspected Drug Date of Onset of Suspected DILI ALT Value at Onset AST Value at Onset Alkaline Phosphatase at Onset Total Bilirubin at Onset Hepatitis A Missing HAV IgM anti-HAV data IgM anti-HAV negative (if total anti-HAV is negative, consider IgM negative as well) IgM anti-HAV positive Hepatitis B Missing IgM anti-HBc serology (note: a (-) anti-HBc total means IgM anti-HBc is done and negative, but a (+) anti-HBc total does not mean IgM anti-HBc was done) HBsAg and IgM anti-HBc negative (if total anti-HBc is negative, consider IgM negative; anti-HBc IgG may be + or - ) HBsAg positive and IgM anti-HBc negative (if total anti-HBc is negative, consider IgM negative; anti-HBc IgG may be + or - ) IgM anti-HBc positive regardless of HBsAg result or missing Hepatitis C Missing anti-HCV or HCV RNA Anti-HCV and HCV RNA both negative Anti-HCV and/or HCV RNA (+) Known Chronic Hepatitis C? Yes No Hepatitis C Exposure Risk in ≤ 100 days prior to onset? Yes No HEV Missing IgM anti-HEV data IgM anti-HEV negative IgM anti-HEV positive Biliary or Parenchymal Disease Missing imaging data Imaging shows no biliary stenosis(es) or obstruction, no malignant infiltration, and no stones in the gallbaldder Imaging shows no biliary stenosis(es) obstruction, but malignant infiltration < 50% of liver and/or stones in the gallbaldder Imaging shows biliary stenosis(es) or obstruction or infiltrating malignancy occupying ≥ 50% of the liver Send